Globe Life (NYSE:GL) Shares Gap Down on Disappointing Earnings

Shares of Globe Life Inc. (NYSE:GL) gapped down before the market opened on Thursday following a weaker than expected earnings announcement. The stock had previously closed at $184.00, but opened at $170.18. Globe Life shares last traded at $172.19, with a volume of 216,922 shares trading hands.

The company reported $3.61 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.67 by ($0.06). Globe Life had a net margin of 19.38% and a return on equity of 20.94%. The firm had revenue of $1.60 billion during the quarter, compared to analysts’ expectations of $1.59 billion. During the same quarter in the previous year, the firm posted $3.05 EPS. The firm’s revenue for the quarter was up 8.0% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS.

Globe Life Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Monday, July 6th will be given a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend is Monday, July 6th. Globe Life’s dividend payout ratio is presently 9.13%.

Key Stories Impacting Globe Life

Here are the key news stories impacting Globe Life this week:

• Positive Sentiment: Globe Life reported second-quarter results showing improved profitability, with net operating income of $3.61 per share versus $3.27 a year ago, while revenue rose 8% year over year to $1.60 billion. Globe Life Inc. Reports Second Quarter 2026 Results
• Positive Sentiment: Reuters and other reports highlighted strong underwriting income, suggesting Globe Life’s core insurance operations are performing well and helping offset the earnings miss. Insurer Globe Life’s second-quarter profit rises on strong underwriting income
• Positive Sentiment: TD Cowen raised its price target on Globe Life to $225 from $215 and kept a Buy rating, while JPMorgan lifted its target to $201 and maintained an Overweight rating, signaling continued analyst confidence. Analyst price target update
• Neutral Sentiment: Globe Life’s EPS of $3.61 missed the consensus estimate of $3.67 by $0.06, which partially offsets the positive revenue and underwriting trends. Globe Life (GL) Q2 Earnings Lag Estimates
• Neutral Sentiment: The company guided FY 2026 EPS to $15.55-$15.95, which is broadly in line with Street expectations and suggests management remains confident but not dramatically more optimistic. Press Release

Wall Street Analysts Forecast Growth

A number of research firms recently commented on GL. Truist Financial increased their target price on shares of Globe Life from $180.00 to $185.00 and gave the company a “buy” rating in a research report on Friday, April 24th. TD Cowen upped their price target on Globe Life from $215.00 to $225.00 and gave the stock a “buy” rating in a research report on Wednesday. Keefe, Bruyette & Woods increased their price objective on Globe Life from $180.00 to $192.00 and gave the company an “outperform” rating in a report on Monday, July 13th. JPMorgan Chase & Co. raised their price objective on Globe Life from $181.00 to $201.00 and gave the stock an “overweight” rating in a research report on Tuesday. Finally, Wells Fargo & Company upped their target price on Globe Life from $172.00 to $193.00 and gave the company an “overweight” rating in a research report on Thursday, July 9th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $187.60.

Insider Activity at Globe Life

In other Globe Life news, CEO James Matthew Darden sold 4,663 shares of the stock in a transaction dated Tuesday, April 28th. The stock was sold at an average price of $153.88, for a total transaction of $717,542.44. Following the sale, the chief executive officer directly owned 58,451 shares of the company’s stock, valued at approximately $8,994,439.88. This trade represents a 7.39% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Cheryl Alston sold 8,258 shares of the firm’s stock in a transaction dated Thursday, June 25th. The stock was sold at an average price of $179.24, for a total value of $1,480,163.92. Following the sale, the director directly owned 16,621 shares in the company, valued at approximately $2,979,148.04. This trade represents a 33.19% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 124,187 shares of company stock valued at $19,529,414 over the last ninety days. Corporate insiders own 2.11% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the stock. CYBER HORNET ETFs LLC purchased a new position in shares of Globe Life in the second quarter valued at approximately $28,000. Hilton Head Capital Partners LLC purchased a new stake in shares of Globe Life during the fourth quarter worth approximately $30,000. MUFG Securities EMEA plc purchased a new stake in shares of Globe Life during the second quarter worth approximately $31,000. Torren Management LLC acquired a new position in Globe Life in the 4th quarter valued at $37,000. Finally, AdvisorNet Financial Inc raised its stake in Globe Life by 41.1% in the 1st quarter. AdvisorNet Financial Inc now owns 316 shares of the company’s stock valued at $44,000 after purchasing an additional 92 shares during the last quarter. Institutional investors and hedge funds own 81.61% of the company’s stock.

Globe Life Stock Down 7.3%

The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.38. The business has a fifty day simple moving average of $168.37 and a two-hundred day simple moving average of $152.54. The company has a market cap of $13.24 billion, a PE ratio of 11.79 and a beta of 0.47.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.